Jim Tananbaum, founder and CEO of Foresite Capital, knows that in order for the healthcare market to meet its crucial mission of providing care to those in need it must succeed in an economic market. This is why Tananbaum’s firm has spent the last six years searching for top-tier talent among healthcare leaders and worked with them so they can increase in profitability so their important work can be carried out.
Having spent time working in healthcare prior to Foresite, Jim Tananbaum co-founded GelTex Pharmaceuticals, which was acquired for $1.6 billion, and as an investor with Prospect Venture Partners, he’s been able to combine elements of both fields to create a dynamic platform for investing. This comes with the understanding that the healthcare market moves relatively slow compared to other industries, and requires foresight to anticipate what can and can’t endure as a viable fund for disparate investing climates. Check out Wired for more info.
But this isn’t simply a question of having enough money to invest over a period of time. Tananbaum has said that seeking out the right talent that operates as leaders in the field. Helping them realize scientific ambitions is the only way to get others excited about investing. These people are easy for Jim Tananbaum to locate thanks to a lifelong love of academia, allowing him to communicate with biomedical researchers without having to work around jargon to grasp their goals and how they plan to reach them.
But even if Tananbaum doesn’t happen upon these people, has encourages more people in the healthcare field to consider entrepreneurship as a means to actualizing their professional ambitions. With so few willing to take the risk necessary to seek success on their own, and entrepreneur could find receptive investors like Forsite with little challenge. All they need, Tananbaum argues, is to believe in them a little more.
About Jim Tananbaum:
Jim Tananbaum is an American investor and healthcare expert. As the founder and CEO of Foresite Capital, Tananbaum employs a method of investment that scouts for exceptional talent in the healthcare field and searches for opportunities to franchise those businesses.
Having finished his formal education at Harvard and the Massachusetts Institute of Technology, Tananbaum went on to form GelTex Pharmaceuticals. That business sold for $1.6 billion in 1998 and started a career as in investment. Visit officialjimtananbaum.com.
Read more: https://ideamensch.com/jim-tananbaum/